Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative interventional technologies intended to transform eye care and improve patients' lives, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the OMNI® Ultra Surgical System (OMNI Ultra) for canaloplasty followed by trabeculotomy for the reduction of intraocular pressure (IOP) in adult patients with primary open-angle glaucoma (POAG).

 SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies with AstraZeneca (LSE/STO/NYSE: AZN). This multi-year collaboration agreement will advance the development and commercialization of two companion diagnostic programs, bringing SOPHiA GENETICS's decentralized clinical trial assays and companion diagnostic capabilities to AstraZeneca therapies. 

Bookmark Medical today announced the completion of its acquisition of Village Medical Michigan, marking the organization's entry into Michigan and expanding its provider-led care network to four states. Effective Aug. 3, 2026, the acquisition brings seven primary care practices, a diagnostic center and Huron Valley Practice Affiliates (HVPA), an independent physician organization, into the Bookmark Medical network. The acquisition includes approximately 40 providers, more than 3

InterSystems, a creative data technology provider powering more than one billion health records globally, today announced the successful deployment of InterSystems TrakCare® across iKang Outpatient，the premium healthcare services brand of iKang Healthcare Group. The TrakCare deployment establishes a unified electronic health record (EHR) solution, resolving issues such as data

Median Technologies manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as Medical Devices (SaMD) for the early detection and diagnosis of cancers, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, today announced the signing of a strategic commercial partnership with Canon Medical Systems Corporation through Canon’s subsidiary Olea Medical, marking an important new step in the executio

The MolinaCares Accord (“MolinaCares”), in collaboration with Molina Healthcare of Indiana (“Molina”), announced a $150,000 grant to Indy Reads to develop new curricula that help adult students better understand healthcare — from talking to doctors, to managing health conditions, to encouraging individuals to take an active role in improving their health. People who understand their health information are more likely to follow their treatment plans and

Epitel, Inc., a leader in AI-driven wireless brain health technologies, announced today the closing of a $26 million Series B financing co-led by Catalyst Health Ventures and Genoa Ventures, with participation from new and existing investors. The funding will support the continued market expansion of the company’s REMI® Remote EEG Monitoring System, allowing extended duration wireless EEG monitoring integrated with AI-driven event detection to improve access to neurological care.

Siemens Healthineers announced today that it has launched capillary testing on the Atellica CH, IM, and CI Analyzers after receiving CE-mark for 24 capillary blood testing claims1, an advancement for capillary testing that offers clinical labs greater confidence in test results and higher throughput. Capillary testing on the Atellica analyzers supports the most common laboratory testing needs – including key assays that comprise the comprehensive metabolic panel, lipid panels, thyroid,

EMeRG today announced the launch of its advanced SaaS intelligence platform, built with a mission to make every hospital visible and every MedTech innovation more accessible. Commercial teams often lack visibility into hospital capabilities, installed technologies and adoption potential. Hospital Intel Suite™ bridges that gap by unifying hospital infrastructure, technologies, clinical capabilities and hundreds of intelligence variables into a single platform. The platform is t

LRE Medical will showcase a connected IVD instrument demonstration at ADLM 2026, illustrating how secure connectivity can be engineered into custom diagnostic systems from the earliest stages of development. Visitors will see how embedded software, cloud connectivity and cybersecurity work together within the instrument architecture to enable remote services, lifecycle management and future AI-enabled applications. As diagnostic instruments become increasingly software-defined, conn